Oprah’s flip on weight loss drugs is a sign of what’s to come for the ‘Ozempic trade’ in 2024
Oprah Winfrey has changed her mind on weight loss drugs and others have, too. What's ahead for the category in
Read MoreOprah Winfrey has changed her mind on weight loss drugs and others have, too. What's ahead for the category in
Read MoreThe health-care sector has seen a big rebound this month, and analysts say some beaten-down names will continue to have
Read More2024 will be another big year for weight loss drugs, which soared in popularity despite hefty price tags, mixed insurance
Read MoreThese are the stocks posting the largest moves in midday trading. Source link
Read MoreThese are the stocks posting the largest moves in premarket trading. Source link
Read MorePfizer on Wednesday forecast 2024 revenue that was below Wall Street expectations and raised its cost-cut target by $500 million.
Read MoreThese five stocks are on pace to end the year with losses, but they could flip the script in 2024.
Read MoreThe study shows that patients and health-care workers should be cautious about relying on OpenAI's viral chatbot for drug information,
Read MoreBefore successful weight loss treatments such as Wegovy and Ozempic, the pharmaceutical path to treating obesity was strewn with failures
Read More